Integrated Investment Consultants’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
5,550
+12
+0.2% +$2.49K 0.21% 73
2026
Q1
$1.24M Sell
5,538
-7
-0.1% -$1.74K 0.26% 64
2025
Q4
$1.34M Buy
+5,545
New +$1.42M 0.26% 67
2025
Q1
– Sell
-6,025
Closed -$1.38M – 334
2024
Q4
$1.38M Buy
+6,025
New +$1.45M 0.28% 66

Other funds holding RMD

Integrated Investment Consultants's RMD Position: Q2 2026 in Review

Integrated Investment Consultants increased its ResMed (RMD) stake by 0.22% in Q2 2026, buying an estimated $2.49K and bringing the position to 5,550 shares worth $1.08M. The position accounts for 0.21% of the portfolio, ranked #73.

Integrated Investment Consultants first reported a position in RMD in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.38M in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Integrated Investment Consultants held 5,550 shares of ResMed worth $1.08M as of Q2 2026.
  • Integrated Investment Consultants bought 12 ResMed shares in Q2 2026, an estimated $2.49K.
  • ResMed made up 0.21% of Integrated Investment Consultants's portfolio in Q2 2026, its #73 holding.
  • Integrated Investment Consultants first reported a position in ResMed in Q4 2024 and has held it in 4 quarters since.
  • Integrated Investment Consultants's ResMed position peaked at $1.38M in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Integrated Investment Consultants's 13F filing for Q2 2026, filed 17 Aug 2026.